The effect of corticosteroid therapy on the development of liver cirrhosis: A clinical case
Open Access
- 18 June 2025
- journal article
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 8,p. 94-99
Abstract
Drug-induced liver damage is a pressing issue in modern pharmacotherapy. The importance of studying this issue is especially high in the current conditions of polypharmacy, hypoor hyperdiagnosis of diseases with insufficiently justified prescription of drugs and their combinations. The article presents a clinical observation of a patient with developed decompensated liver cirrhosis after pulse therapy with methylprednisolone. The patient complained of severe pain and weakness in the lower extremities, was examined by a neurologist due to suspected multiple sclerosis – the diagnosis was not confirmed. Later, she was hospitalized for further diagnostics, an MRI study was performed with the detection of a few focal changes, which were interpreted as a demyelinating disease of the central nervous system, as a result of which pulse therapy with methylprednisolone was prescribed. She was discharged with positive dynamics, was observed on an outpatient basis in the multiple sclerosis office, did not lead a healthy lifestyle, there were episodes of drinking alcoholic beverages. Four months after the last hospitalization, the patient’s condition worsened, weakness and shortness of breath appeared. She was hospitalized and after a long diagnostic search, the final diagnosis was established: Unspecified liver cirrhosis. MELD = 22 points, Child-Pugh class B. The described clinical case is an example of the development of severe drug-induced liver injury induced by pulse therapy with methylprednisolone. Multiple sclerosis has a number of common features with other pathologies, therefore, to establish a diagnosis, it is necessary to conduct a detailed and comprehensive examination of the patient. It is important to exclude other possible diseases. Unreasonable and premature administration of corticosteroids can lead to drug-induced liver injury.Keywords
This publication has 12 references indexed in Scilit:
- Uncovering alternative diagnoses in patients with clinical syndromes suggestive of multiple sclerosis: A transversal study from the prospective Barcelona CIS cohortMultiple Sclerosis Journal, 2025
- Differential diagnosis of suspected multiple sclerosis: an updated consensus approachThe Lancet Neurology, 2023
- Acute liver injury following methylprednisolone pulse therapy: 13 cases from a prospectively collected cohortEuropean Journal of Gastroenterology & Hepatology, 2021
- Small Intestinal Bacterial Overgrowth Diagnosed by a Breath Test and Improved by Rifaximin in a Patient with Hepatic Encephalopathy and Alcoholic Liver CirrhosisInternal Medicine, 2020
- Frequency, characteristics and impact of multiple consecutive nosocomial infections in patients with decompensated liver cirrhosis and ascitesUnited European Gastroenterology Journal, 2020
- Adverse outcomes of proton pump inhibitors in chronic liver disease: a systematic review and meta-analysisHepatology International, 2020
- Liver injury after methylprednisolone pulses: A disputable cause of hepatotoxicity. A case series and literature reviewUnited European Gastroenterology Journal, 2019
- The nosological structure of years of potential life lost in the economically active age in the Russian Federation in 2016Russian Journal of Preventive Medicine, 2019
- Methylprednisolone-induced hepatotoxicity in a 16-year-old girl with multiple sclerosisBMJ Case Reports, 2018
- Alternative diagnoses in patients referred to specialized centers for suspected MSMultiple Sclerosis and Related Disorders, 2017